JMP Securities Reiterates Market Outperform on Rallybio, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jonathan Wolleben has reiterated a Market Outperform rating on Rallybio (NASDAQ:RLYB) and maintained an $8 price target.
April 18, 2024 | 5:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JMP Securities analyst Jonathan Wolleben reiterated a Market Outperform rating on Rallybio, with an $8 price target.
The reiteration of a Market Outperform rating and maintenance of an $8 price target by a reputable analyst like Jonathan Wolleben from JMP Securities could instill confidence among investors and potentially lead to a positive short-term price movement for Rallybio.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100